Busulfan
Myleran (busulfan) is an oral tablet used as chemotherapy to treat certain blood cancers like chronic myeloid leukemia. It works by damaging cancer cells' DNA. Each tablet contains 2 mg of busulfan and is prescribed by a doctor. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Myleran (busulfan) is an oral tablet used as chemotherapy to treat certain blood cancers like chronic myeloid leukemia. It works by damaging cancer cells' DNA. Each tablet contains 2 mg of busulfan and is prescribed by a doctor. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Busulfan",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Busulfan — ANDA 207050 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207050"
}
]
|
| identifier | ANDA207050 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"health-care",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Busulfan |
